Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

2 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Pharmacogenetic and Pharmacogenomic Research - Pharmacogenetic and Pharmacogenomic Research

- 25/09/2017 - 1 Formulaire, 1 Groupe Item, 10 Eléments de données, 1 Langue
Groupe Item: PGx-Pharmacogenetic/PGm-Transcriptomic/PGM-Proteomic Research
A 24 week double-blind, randomised, placebo-controlled, parallel-group dose-ranging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer's disease.

GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)

- 31/08/2017 - 1 Formulaire, 13 Groupes Item, 59 Eléments de données, 1 Langue
Groupes Item: General Information, Orthostatic Vital Signs, Baseline PLMI, Polysomnography, Baseline Inclusion Criteria, Baseline Exclusion Criteria, RLS rating scales, Vital signs, Concomitant Medication, Medical Procedures, Baseline Signs and Symptoms, Baseline Employment Status, Ramos Randomization and dispensing
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial